Tennessee bills · 114th Regular Session (2025-2026)
Tennessee SB 2499
TennCare - As introduced, requires a managed care organization or pharmacy benefits manager that is contracted with the bureau to reimburse a claim for a long-acting injectable drug intended for treatment and prevention of human immunodeficiency virus and administered in a pharmacy, physician's office, clinic, ambulatory surgical treatment center, or hospital. - Amends TCA Title 4; Title 56 and Title 71.
- Introduced
- In committee
- Passed Senate
- Passed House
- To Governor
- Became law
Sponsors
- Kyle (Democratic)
Summary
No official summary is available for this bill.
Latest action(Mar 10, 2026): Assigned to General Subcommittee of Senate Commerce and Labor Committee
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Mar 10, 2026 · House
Assigned to General Subcommittee of Senate Commerce and Labor Committee - Mar 5, 2026 · Senate
Passed on Second Consideration, refer to Senate Commerce and Labor Committee - Mar 4, 2026 · House
Placed on Senate Commerce and Labor Committee calendar for 3/10/2026 - Mar 2, 2026 · House
Approved by Delayed Bills Committee - Mar 2, 2026 · House
Introduced, Passed on First Consideration - Feb 2, 2026 · House
Filed for introduction - Feb 2, 2026 · House
Refer to Senate Delayed Bills Committee